山西省拟认定3个化工园区
世界农化网中文网报道：近日，山西省工信厅公示了山西省化工园区（第七批）拟认定名单。
全球首款RNA杀菌剂墨西哥获批；Sipcam Nichino在巴西20年来最大创新；武汉设生物”国家队” | BioEx情报速览
本周速览：墨西哥批准全球首款RNA生物杀菌剂；植物源杀螺剂、RNAi递送新平台、GLLc（糖-木质素-脂质）分子复合物生物刺激剂亮相；阿根廷监管松绑；戴商高士整合中国三品牌；武汉设立微生物农药评价中心，生物制剂产业链条加速成型。
Oatly’s New Packaging Spotlights Public Clamour for Governments to Tackle Climate Change
A year after being named the world’s first climate solutions company in the food and beverage category, Oatly is now illustrating the “ultimate climate solution” on its oat milk cartons.
Saanroo study reveals serum cuts gray hair by 15.5% as pro-aging reshapes hair care
Saanroo has published the first clinical study of its HairAge Vitae ingredient on hair pigmentation, reporting a 15.5% reduction in gray hair density among adults who applied a topical serum for 12 weeks.
Shinsung Materials secures US standard and Korean patent for UV-A filter
Shinsung Materials has secured a Korean patent and achieved US quality standards for its high-purity, water-soluble Ecamsule UV-A filter. The company says the development could broaden the ingredient’s applications in cosmetic formulations.
水稻+抗性禾本科杂草：首个具有酰胺结构的HPPD分子正在进入”验证期”
编者按：美国环保署（EPA）近日公布，已收到日产化学株式会社提交的两项Iptriazopyrid产品登记申请，分别为98.5%原药（Technical）和100 g/L悬浮剂（SC），拟用途均为水稻田除草。目前，两项申请仍处于EPA审查及公众评论阶段。
6家农药上市公司2026半年报新出炉：利尔、泰禾、丰山、新农、农心、广康
世界农化网中文网报道： 近日，利尔化学、泰禾股份、丰山集团、新农股份、农心科技和广康生化等农药上市公司披露2026年半年度报告，业绩表现如下：
泰禾股份2026上半年营收净利双增，创制药环丙氟虫胺销售2.83亿元
世界农化网中文网报道：8月28日，南通泰禾化工股份有限公司（简称″泰禾股份″）披露2026年半年度报告。
EU microplastics ban pushes beauty from ingredient swaps to manufacturing change
The European Union (EU) is cracking down on microplastics intentionally added to cosmetics due to their environmental persistence. Turning to bio-based formulations could help cosmetic manufacturers skirt upcoming bottlenecks, but at scale, these materials present formulation challenges. Experts suggest that it may be time for the beauty industry to update its manufacturing processes.
Molecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection Identified
When the immune system encounters a virus, it produces antibodies designed to recognize and eliminate the invader. But in some people infected with SARS-CoV-2 the immune response goes awry, producing autoantibodies that mistakenly attack the body’s own tissues.